Preclinical Evaluation of the Phosphodiesterase-4 Inhibitor, Rolipram, in an Infant Model of Sepsis-Induced Cardiorenal Syndrome

被引：0
|
作者：
Sims, Clark R. [1 ]
Singh, Sharda P. [1 ,2 ]
Mayeux, Philip R. [1 ]
机构：
[1] Univ Arkansas Med Sci, Little Rock, AR 72205 USA
[2] Cent Arkansas Vet Healthcare Syst, Little Rock, AR USA
来源：
FASEB JOURNAL | 2016年 / 30卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
1200.6
引用
收藏
页数：2
相关论文
共 50 条
  • [41] ROLIPRAM, A PHOSPHODIESTERASE 4 INHIBITOR, PROTECTS DEVELOPING NEURONS AGAINST ALCOHOL-INDUCED CELL DEATH
    Karacay, B.
    Mahoney, J.
    Bonthius, D. J.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2017, 41 : 222A - 222A
  • [42] Effect of phosphodiesterase-4 inhibitor on the inflammation, oxidative damage and apoptosis in a saline lavage-induced model of acute lung injury
    Kosutova, Petra
    Mikolka, Pavol
    Kolomaznik, Maros
    Balentova, Sona
    Calkovska, Andrea
    Mokra, Daniela
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [43] The effect of the novel phosphodiesterase-4 inhibitor MEM 1414 on the allergen-induced responses in mild asthma
    Leaker, B. R.
    Singh, D.
    Barnes, P. J.
    Imrie, M.
    Hughes, R.
    O'Connor, B.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 181
  • [44] Treatments increasing synaptic noradrenaline enhance phosphodiesterase-4 inhibitor R-[11C]rolipram binding in vivo in rat heart.
    Kenk, M
    Lourenco, CM
    Houle, S
    Beanlands, RS
    DaSilva, JN
    JOURNAL OF NUCLEAR MEDICINE, 2003, 44 (05) : 193P - 194P
  • [45] Anti-proliferative properties of the phosphodiesterase-4 inhibitor rolipram can supplement immunosuppressive effects of cyclosporine for treatment of obliterative bronchiolitis in heterotopic rat allografts
    Roth-Eichhorn, S
    Schade, I
    Kasper, M
    Ploetze, K
    Wunderlich, J
    Funk, RHW
    Schueler, S
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2001, 20 (11): : 1188 - 1198
  • [46] Effects of Roflumilast, a Phosphodiesterase-4 Inhibitor, on Hypoxia- and Monocrotaline-Induced Pulmonary Hypertension in Rats
    Izikki, Mohamed
    Raffestin, Bernadette
    Klar, Juergen
    Hatzelmann, Armin
    Marx, Degenhard
    Tenor, Hermann
    Zadigue, Patricia
    Adnot, Serge
    Eddahibi, Saadia
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2009, 330 (01): : 54 - 62
  • [47] Evaluation of immune and pyroptosis status in a model of sepsis-induced secondary pneumonia
    Li, Fei
    Han, Xinjing
    Wu, Chuanxin
    He, Jiahui
    Liu, Huang
    Li, Shuhua
    Li, Li
    Long, Xianli
    Sun, Hang
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 140
  • [48] Apremilast, a cAMP phosphodiesterase-4 inhibitor, demonstrates anti-inflammatory activity in vitro and in a model of psoriasis
    Schafer, P. H.
    Parton, A.
    Gandhi, A. K.
    Capone, L.
    Adams, M.
    Wu, L.
    Bartlett, J. B.
    Loveland, M. A.
    Gilhar, A.
    Cheung, Y-F
    Baillie, G. S.
    Houslay, M. D.
    Man, H-W
    Muller, G. W.
    Stirling, D. I.
    BRITISH JOURNAL OF PHARMACOLOGY, 2010, 159 (04) : 842 - 855
  • [49] Clinical Efficacy of a Selective Phosphodiesterase-4 Inhibitor (Roflumilast) in Patients with Chronic Obstructive Pulmonary Disease and Metabolic Syndrome
    Ignatova, G.
    Blinova, E.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [50] Ibudilast, a Phosphodiesterase-4 Inhibitor, Ameliorates Acute Respiratory Distress Syndrome in Neonatal Mice by Alleviating Inflammation and Apoptosis
    Yang, Dongjie
    Yang, Yihan
    Zhao, Yue
    MEDICAL SCIENCE MONITOR, 2020, 26
12345